Skip Navigation
Menu
Original Research |15 January 1996

Neurotoxicity Related to the Use of Topical Tretinoin (Retin-A)

Allan L. Bernstein, MD; Jeanne L. Leventhal-Rochon, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
Copyright ©2004 by the American College of Physicians
2004
  • From the Kaiser Permanente Medical Center, Hayward, California. Acknowledgments: The authors thank Hemmige Bhagavan, PhD, Hoffmann-La Roche, Inc., Nutley, New Jersey, for reviewing the manuscript and for providing helpful suggestions, and the Medical Editing Department, Kaiser Foundation Research Institute, for editorial assistance. Requests for Reprints: Allan L. Bernstein, MD, Department of Neurology, Kaiser Permanente Medical Center, 401 Bicentennial Way, Santa Rosa, CA 95403-2192.
×
FULL TEXT
Topical tretinoin (Retin-A, Ortho, Raritan, New Jersey), a vitamin A analog, has been used to treat acne vulgaris since 1972 in the United States. Oral [1], but not topical [2], forms of vitamin A have been associated with neurologic complications, and systemic absorption through intact skin is minimal [3]. The package insert of topical tretinoin includes no warning about neurotoxicity [4]. We report a case of neurologic and psychiatric symptoms that resolved after use of topical tretinoin was discontinued.
A 39-year-old woman was healthy except for mild, untreated depression and chronic hepatitis C. She had used...
FULL TEXT
PDF
Not Available
Citations
Citation

Bernstein AL, Leventhal-Rochon JL. Neurotoxicity Related to the Use of Topical Tretinoin (Retin-A). Ann Intern Med. 1996;124:227–228. doi: https://doi.org/10.7326/0003-4819-124-2-199601150-00006

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1996;124(2):227-228.

DOI: 10.7326/0003-4819-124-2-199601150-00006

6 Citations

Related Articles
Association Between Statin Use and Risk for Keratinocyte Carcinoma in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
Annals of Internal Medicine; 150 (1): 9-18
High Risk for Hyperlipidemia and the Metabolic Syndrome after an Episode of Hypertriglyceridemia during 13-cis Retinoic Acid Therapy for Acne: A Pharmacogenetic Study
Annals of Internal Medicine; 136 (8): 582-589
All-trans Retinoic Acid for Acute Promyelocytic Leukemia: Results of the New York Study
Annals of Internal Medicine; 120 (4): 278-286
Topical Tretinoin and Vaginal Bleeding
Annals of Internal Medicine; 114 (1): 97
View MoreView Less

Related Topics
Emergency Medicine
Neurology

Emergency Medicine, Neurology.

PubMed Articles
CAR T-cell therapy: is it prime time in myeloma?
Hematology Am Soc Hematol Educ Program 2019;2019(1):260-265.
Melasma Treatment: An Evidence-Based Review.
Am J Clin Dermatol 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×